“Teneligliptin Pharmacokinetics with Age in Japanese and European Descent Populations Shows Limited Impact on Maximum Concentration”

https://pubmed.ncbi.nlm.nih.gov/38117459

The pharmacokinetics of the drug teneligliptin shows a slight increase in exposure (AUC) with age, but the maximum concentration (Cmax) is less affected by age in both Japanese and European descent populations.